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Nothing in life is to be feared, it is only to be understood. Now is the time to understand 







Perioperative complications is an increasing issue worldwide, as surgical volume continues to 
grow. Myocardial and kidney injury, and myocardial infarction (MI), are known 
complications in non-cardiac surgery. Hemodynamic instability during anaesthesia and 
surgery, the association with perioperative complications, and optimal blood pressure 
threshold in the perioperative period, have been topics of increasing interest since this thesis 
idea was formed.  
 
The thesis aime is to increase our knowledge of perioperative organ injury and to understand 
its aetiology: to evaluate the relation between preoperative risk factors – comorbid burden – 
and intraoperative risk factors, with a special focus on intraoperative hemodynamic 
variability.  
 
All studies are observational by design and epidemiologically approached. Regional and 
national registers, and medical records, are used in the data collection. Study I is a descriptive, 
registry-based, cohort study of more than 400 000 operated adult patientes in 22 Swedish 
hospitals between 2007 and 2014. Study II and III are cohort studies enrolling adult patients 
undergoing major non-cardiac surgery att the Karolinska University Hospital, 2012 to 2013 
and 2015 to 2016. Study IV use a case-control study design, nested within the cohort collected 
in study I. 
 
In summary, this thesis illuminates how comorbid patients, undergoing major non-cardiac 
surgical procedures, are at increased risk of perioperative cardiac and kidney morbidity. 
Development of myocardial or kidney injury, or clinically significant MI in the perioperative 
period is associated with short- and longterm mortality. This elderly, high-risk surgical 
population should be targeted to improve perioperative outcomes. Intraoperative hypotension 
is associated with myocardial and kidney injury and is a major contributor to clinically 
significant perioperative MI. The high absolute risk of MI development associated with 
intraoperative hypotension, among a growing population of patients with a high risk-burden, 
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Chapter 1. Introduction 
Epidemiology 
In Sweden, more than 800 000 patients undergo surgery each year.1 Worldwide, the number 
of surgical procedures yearly is over 310 million.2 Surgical care is an essential part of the 
advancement in treating disease, associated with increased life expectancy and improved 
quality of life. However, as surgical volume continues to grow, the number of patients who 
suffer postoperative complications will also increase. Older surgical patients with 
multimorbidity sustain complications more frequently, an important determinant of decreased 
postoperative survival.3,4 In a large international study of postoperative outcomes, evaluating 
the global incidence and risk factors for complications and death after elective inpatient 
surgery in adults, 1 out of 6 patients developed complications with associated five-fold 
increased mortality rates.5 
Anaesthesia-related mortality has dramatically declined over the past half century. In a global 
meta-analysis, 34 deaths per million surgeries were attributed to the anaesthesia in developed 
and developing countries.6 Despite major advances in the delivery of safe anaesthesia, 
perioperative morbidity and mortality remain a major public health problem.7  In a study of 
an inpatient surgical population for the year 2006, perioperative death prior to discharge or 
within 30 days following elective open surgery was the 3rd leading cause of death,8 exceed 
only by heart disease and cancer in the general population. 
This thesis aims to increase our knowledge of perioperative organ injury and to understand its 
aetiology: to evaluate the relation between preoperative risk factors – comorbid burden – and 
intraoperative risk events, with a special focus on intraoperative hemodynamic variability.
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Perioperative organ injury 
Regardless of many advances in the perioperative care, acute organ injury leading to single or 
multiple organ failure remains a serious consequence following surgery. Systemic 
inflammatory response syndrome due to the surgical trauma has been suggested as a trigger 
in surgical patients.8 A number of studies have shown associations with patient preoperative 
comorbidities and intraoperative factors, such as hemodynamic stability, blood- and fluid 
administration.9-11 Stroke, myocardial infarction (MI), acute respiratory distress syndrome 
(ARDS), acute kidney injury (AKI), and acute gut injury (AGI) are among the most common 
morbidities and causes of mortality in surgical patients.8,12-15 
Perioperative myocardial injury and infarction 
MI is traditionally divided into different types; MI type 1 is due to occlusive coronary artery 
disease, plaque rupture and thrombosis, whilst MI type 2 is characterised by an oxygen 
supply-demand imbalance, when other conditions than atherosclerotic disease and the usual 
thrombotic plaque rupture contributes to oxygen insufficiency.16 Even as MI type 1 and 2 
have different underlying mechanisms, both conditions are traditionally associated with 
ischemia in the myocardium. Myocardial ischemia is by definition the result of disturbances 
in myocardial perfusion due to an imbalance in oxygen demand and delivery, the myocardial 
cells are not receiving enough oxygen to perform their work optimally. If oxygen delivery is 
not increased and/or workload reduced, and the imbalance restored, myocardial necrosis and 
cell death will follow. 
Table 1. Classification of myocardial injury, derived from the fourth universal definition of acute MI.16,17 
Classification Definition 
Acute MI Clinical evidence of acute MI: 
- - Symptoms of myocardial ischemia 
- - New ischemic ECG changes and/or Q waves 
- - Imaging evidence of new loss of vialbe myocardium or regional 
abnormalities consistent with ischemic aetiology 
- - Coronary thrombus identification by angiography/autopsy 
MI type 1 Atherothrombotic coronary artery disease, usually precipitated by 
atherosclerotic plaque disruption. 
MI type 2 Mismatch between oxygen supply and demand by a pathophysiological 
mechanism other than coronary atherothrombosis. 
Acute non-ischemic myocardial 
injury 
Acute myocardial injury (rise and fall of cardiac biomarkers) in the 
absence of a primary ischemic cause (i.e. MI) 




However, MI type 2 may arise in various non-ischemic medical and surgical conditions.18 
This type of infarction is frequent in critically ill patients, or in patients undergoing 
anaesthesia and surgery, where high levels of catecholamines and/or direct toxic effects of 
endogenous toxins might be the cause.16 The term MI type 2 has been questioned for many 
reasons, one being that there are no evidence-based treatment strategies. Cardiac troponin 
elevation, without other features of infarction, i.e. ECG changes or symptoms, is formally 
entitled myocardial injury, an even more vague diagnosis. These cardiac conditions are 
frequently confused. Secondary myocardial injury, followed by a description of the 
underlying cause, ischemic/non-ischemic, has been an alternative suggested terminology.19  
Figure 1. Classification of myocardial injury.17 
 
Patients with cardiovascular and atherosclerotic disease, with underlying fixed atherosclerotic 
plaques and/or endothelial dysfunction, are at particularly high risk in the perioperative 
period, due to the high risk of tachycardia, hypotensive and/or hypoxic episodes, contributing 
to the oxygen supply/demand imbalance. Defining myocardial ischemia and infarction in the 
perioperative setting is particularly difficult due to the absence of classic ischemic symptoms. 
Most perioperative MI’s occur during or closely (24-48 hours) after surgery,20 when patients 
receive analgesics and sedatives, limiting their ability to recognize and communicate 
symptoms. Postoperative signs, like hypotension and tachycardia, or symptoms, as shortness 



















other complications, such as atelectasis, pneumonia, hypovolemia or medication side 
effects.21 Nevertheless, myocardial infarction, symptomatic or asymptomatic, has an equally 
poor prognosis.20 
There are several definitions of myocardial injury (damage) in the perioperative setting in the 
literature; perioperative myocardial injury (PMI), major adverse cardiac events (MACE) and 
myocardial injury after non-cardiac surgery (MINS) being the most established. 
Independently of the terminology, they are united by the fact that their definition relies on 
biomarkers. The incidence varies because of lack of consensus in the definition as described 
below. An incidence of 2-3% within 30 days after non-cardiac surgery has been reported,22 
approximately affecting more than 10 million patients each year worldwide. In a recent study 
of high-risk non-cardiac surgical patients, an incidence of 16% was found and followed by a 
substantial association with short- and long-term mortality.23 
Cardiac biomarkers 
Troponins are the biomarkers of choice in diagnosing myocardial injury and infarction. They 
are proteins expressed both in skeletal and cardiac muscles and exist in several different 
isoforms, such as troponin I and troponin T. In addition, there are many different assays with 
varying cut-off levels for diagnosing MI.24 Since perioperative myocardial injury and 
infarction often are detected solely by biomarkers, comparison between different studies is 
challenging. The newest high-sensitivity cardiac troponin-T (hs-cTnT) assay is the most 
cardiac-specific biomarker and has improved identification of clinically silent myocardial 
ischemia, as in the perioperative period. Hs-cTnT improves risk assessment and enables 
identification of more patients with – or at risk of – myocardial injury and new cardiac 
ischemic events.25 However, improvements in assay sensitivity may lead to over-diagnosis. 
Coupled with a decreased specificity this calls for consideration of differential diagnoses. 
Even though hs-cTnT is highly specific for myocardial injury, the underlying cause might be 
related to many different chronic conditions without cardiomyocyte necrosis.26 Elevated 
levels are often detected, in absence of acute coronary syndrome, in elderly27 and in patients 
with chronic renal dysfunction, septic conditions, atrial fibrillation and congestive heart 
failure. Therefore higher cut-off levels have been suggested in these patients.24,28 Although 
the aetiology of increased levels of hs-cTnT in plasma remains uncertain, whether from 
increased production or decreased clearance, elevated levels are associated with poor 
prognosis.29 Recent studies suggest that postoperative elevated troponin levels are 
independently associated with increased mortality after non-cardiac surgery.30 
 
 5 
Figure 2. Classification of myocardial ischemia, definitions based on cardiac troponins.31  
 
 
   
Perioperative kidney injury 
Acute kidney injury (AKI) is characterised by a sudden decline in renal function and 
diagnosed by a rise in serum creatinine or a decrease in urine output. AKI is associated with 
short- and long term mortality and morbidity.32 The KDIGO criteria is a classification system 
of AKI, categorizing the condition into three different stages depending on increase in serum 
creatinine or decrease of urine output.33 
Table 2. Staging of acute kidney injury (AKI) according to KDIGO criteria.33 
Stage Serum creatinine Urine output 
1 1.5 to 1.9 times baseline or ≥0.3 mg/dl (≥26.5 μmol/l) increase <0.5 ml/kg/hour for 6 to 12 h 
2 2.0 to 2.9 times baseline <0.5 ml/kg/hour for ≥12 h 
3 3.0 times baseline or increase in serum creatinine to ≥4.0 mg/dl 
(≥353.6 μmol/l) or initiation of renal replacement therapy or in 
patients <18 years a decrease in GFR to <35 ml/minute per 1.73 m2 
<0.3 ml/kg/hour for ≥24 h 
or anuria for ≥12h 
Elevated Cardiac Troponin value
(99th percentile, URL) 
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Perioperative AKI is common, with a recent study of major abdominal surgery showing an 
incidence of 13 percent.34 Incidence of AKI after cardiac surgery has been studied more, 
using the KDIGO criteria in a retrospective analysis 42% of the patients developed AKI 
postoperatively.35 In a systematic review and meta-analysis, including 91 observational 
studies and 320 086 cardiac surgery patients, a pooled AKI incidence rate of 22.3% (95% CI 
19.8 to 25.1) was reported.36  
The aetiology of AKI is complex. A common feature of many processes causing AKI is a 
reduction in regional renal oxygen delivery, leading to inflammation, ischemia and, possibly, 
necrosis.37,38 A surgical inflammatory trauma likely increases the risk of AKI and 
intraoperative factors like hypotension, bleeding and hypoxia may add insult to injury. A 
decrease in haemoglobin concentration during surgery has been identified as a risk event 
associated with post-operative AKI.10 In patients with severe anaemia, the independent effect 
of hypotension on AKI in the perioperative period was more pronounced, supporting the 
pathophysiological theory above, where additive harmful factors lead to a more aggravated 
outcome. Some of these events are modifiable in the perioperative setting. 
In addition, fluid overload has been suggested as an important contributor to AKI.39 Increased 
renal venous pressure could theoretically result in a reduction of the trans-renal pressure 
gradient for renal blood flow. The subsequent elevated interstitial and tubular pressure might 
affect - diminish - the net glomerular filtration pressure gradient. Whilst there are troves of 
observational data supporting the association between fluid overload and AKI,39 standard 
treatment of low cardiac output and hypotension involving fluid bolus therapy makes this 
confounder especially confounding. Nevertheless, a recent review suggested that the 
hemodynamic management of the elderly surgical patient should focus on 




Hemodynamic instability in the perioperative period is common and there has been a 
cumulative interest in this area, and the relation to organ failure, over the recent years. 
Hypotensive episodes are particularly frequent during the anaesthetic induction, related to the 
cardio-depressant and vasodilating effect of anaesthetic agents.41,42 Inhalational anaesthesia 
with Sevoflurane has previously been regarded as cardio-protective,43,44 although the 
evidence is questioned. A comparison with Propofol-maintained anaesthesia revealed an 
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advantage in maintaining hemodynamic stability during surgery with Sevoflurane.45 
Intraoperative hypotension may also be the result from blood loss, fluid shifts and cytokine 
release during surgery.46  
There are several studies showing results of associations between intraoperative hypotensive 
events and perioperative cardiac, kidney and cerebral injury, and increased mortality in in 
high-risk surgical patients.9,11,22,47-50 However, consensus is still lacking regarding optimal 
blood pressure thresholds to achieve adequate perfusion and oxygenation in critical organs 
during anaesthesia and surgery and there are no general recommendations regarding lowest 
acceptable perioperative blood pressure. Numerous different definitions of hypotension in a 
perioperative setting exist in the literature, a review of intraoperative hypotension identified 
as many as 140 definitions in 130 studies.51 Binary cut-offs are commonly used to define 
intraoperative hypotension, as mean arterial pressure (MAP) below 55mmHg or systolic 
blood pressure (SPB) below 80mmHg, and associations with increased risk of organ damage 
and mortality have been shown.9,11,47 But these binary cut-offs may introduce a distortion and 
individually based intraoperative hypotension definitions have been proposed. 
Importantly, perioperative hemodynamic instability can be avoided, or at least minimized, in 
most clinical situations. Through attentive medical treatment, with vasoactive drugs, and the 
use of protocolized hemodynamic algorithms, to guide delivery of intravenous fluids and 
maximize stroke volume, it is often possible to maintaining adequate intravascular volume 




Aims of the thesis 
 
The overall aim of this project was to increase our knowledge of perioperative organ injury 
and to understand its aetiology: to evaluate the relation to preoperative risk – comorbid 
burden – and intraoperative risk factors, with a special focus on intraoperative hemodynamic 
variability. 
 
Specific aims were: 
I. To report the incidence of MI, defined according to the universal definition,16  after 
non-cardiac surgery in Sweden and to study the association with preoperative risk 
factors. 
 
II. To investigate how intraoperative events, with focus on hypotension, are related to 
perioperative myocardial injury, to evaluate the impact of preoperative risk factors  
and to study the association with MI. 
 
III. To examine how intraoperative hypotension is related to perioperative AKI and to 
evaluate the impact of other potential risk factors including; comorbidities, blood loss 
and fluid overload.  
 
IV. To test the hypothesis that IOH is an independent risk factor for clinically significant 
perioperative MI in a high-risk non-cardiac surgical population.  
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Chapter 2. Methods 
ETHICAL CONSIDERATIONS 
All studies, I-IV, included in this thesis have ethical permission approved by the Regional 
Ethics Committee of Stockholm, Sweden. The studies are conducted in accordance with the 
Helsinki declaration  and good clinical practice. This is registry-based research, which carries 
no deviation from clinical routine nor does it involve any direct contact with the study 
participants, hence, no personal consent is needed from the study participants to obtain 
approval.52 All studies are observational, there are no procedures involving pain, discomfort 
or risk of complications. Potential ethical aspects of the project are related to the risk of 
violating patients’ integrity when collecting data from the medical chart. However, 
individuals usually benefit from registry-based research since knowledge about personal 
history and risk factors associated with their disease is increased. One could argue that 
individuals participating have more to gain more than they have to lose, since registry-based 
research does not involve any liabilities to the study participants. Data included in these 
studies are stored pseudonymized, there is a key and a possibility to define the true identity of 
individuals in a dataset, and, subsequently, an opportunity to link these individuals to new 
data or to update their medical history, if needed. The key file (between the personal identity 
number and serial number) is stored at the agency responsible for the data matching, the 
National Board of Heatlh and Welfare. 
 
DATA SOURCES 
The Orbit Register 
Orbit is a software program to administer surgical procedures used by approximately 40% of 
Swedish hospitals of all levels (university, county and district hospitals). The Orbit registry 
obligatory includes the Swedish identity number, patient demographics, elective or non-
elective status, type-, extent- and duration of anaesthesia and surgery. Orbit was used to 
identify the surgical study population in these studies. 
The National Board of Health and Welfare 
In Sweden, the tradition of registry establishment and high-quality record keeping extends far 
back. The National Board of Health and Welfare (NBHW), a Swedish government agency, is 
responsible for maintaining health data registers and official statistics of health, medical care 
and social services.53 The statistical database includes statistics on a number of diseases, 
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including acute myocardial infarctions, causes of death and in-patient care diagnoses. 
Statistics are presented by year, age and geographical area.54 The unique personal identity 
number assigned to all Swedish citizens at birth, or at immigration, allows linkage to all 
national registers.55 
The National Patient Register, established in 1964 and maintained by the NBHW, contain 
information on all in-patient somatic and psychiatric care with complete coverage since 
1987.56,57 Discharge diagnosis is registered according to the International Classification of 
Diseases (ICD-SE) coding, the 10th version has been used in Sweden since 1997.58 
The Swedish Cause of Death Registry, established in 1961, includes the deaths of all Swedish 
citizens and residents with a national identity number; it is highly reliable with over 99% of 
all deaths reported.59,60 The primary cause of death, defined as the disease of condition 
leading to death, is registered according to ICD-10 codes, acquired from the obligatory death 
report submitted to the NBHW by the responsible physician. Misclassifications exist, a report 
from 2010 estimated the risk to approximately 20%, with an age-dependent variation.61  
The Swedish Prescribed Drug Register, another registry managed by the NBHW, became 
operational in July 2005 and contain data on all dispensed prescriptions of drugs in 
Sweden.62,63  
The Total Population Register 
Statistics Sweden (SCB) is responsible for coordinating the system for official statistics in 
Sweden. The Total Population Register (TPR) is maintained by SCB64 and contain data on 
birth and death (100% reported to the population register within 30 days), name change, 
family relationships, migration and immigration. Through the personal identity number, data 
from TPR can be used for medical purposes and allows identification of general population 
controls and participants in cohort studies.65 
National Quality Registries 
In Sweden, a number of Quality Registries have been developed. These registries contain 
patient data information on individual level, including background factors, diagnoses, 
medical interventions and outcome after treatment. All data is annually monitored and 
approved by an Executive Committee. National Quality Registries in Sweden provide a 




Swedeheart (National Quality Registry for Enhancement and Development of Evidence-
Based Care in Heart Disease) is a national quality registry containing data on acute coronary 
care, coronary angiography, cardiac surgery, secondary prevention and genetic cardiovascular 
diseases. The Swedeheart registry provide a platform for continuous improvement measures 
that, in the long-term, may contribute to a reduction in cardiovascular morbidity and 
mortality. Swedeheart contains, among others, data on all patients with acute myocardial 
infarction and all patients undergoing angiographic coronary intervention and heart surgery.67 
 
DEFINITIONS 
Perioperative MI was defined according to the universal definition by the joint European 
Society of Cardiology (ESC) and American College of Cardiology (ACC) consensus,31 
occurring within 30 days of surgery. MI diagnoses were identified using ICD-10-SE 
diagnosis codes (I21.0-I21.4), acute transmural, subendocardial and unspecified MI, thus 
including both MI type I and type II. 
Myocardial injury (damage) was defined as elevated levels of the cardiac biomarker, hs-
cTnT >14 ng/L, on postoperative day one. 
Perioperative AKI, was determined, according to the KDIGO criteria,33 as a rise in 
creatinine; >1.5 times or ≥26.5 μmol/l, increase from individual baseline preoperative 
creatinine, within the first two postoperative days. Hence, the highest creatinine value on 
postoperative morning 1-3 was used for the AKI staging. 
Intraoperative hypotension was defined as a decrease in SBP from patients’ individual 
baseline lasting >5 minutes. 
The ASA classification, the American Society of Anaesthesiologists physical status 
classification, is a simple five-degree categorization of a patient’s physical status, developed 
to be helpful in predicting operative risk.68 The ASA classification originated in 1941, after 







Table 3. The American Society of Anaesthesiologists physical status classification.68 
Classification Definition 
ASA 1 A normal healty patient, non-obese (BMI <30), nonsmoking with good exercise 
capacity. 
ASA 2 A patient with a mild (well-controlled) systemic disease, with no functional 
limitations; (e.g. treated hypertension, obesity with BMI <35, frequent social 
drinker or smoker). 
ASA 3 A patient with a severe systemic disease, with functional limitations but not life-
threatening; (e.g. poorly treated hypertension or diabetes, morbid obesity, 
chronic renal failure, bronchospastic disease with intermittent exacerbations, 
stable angina, implanted pacemaker). 
ASA 4 A patient with severe systemic disease, with severe functional limitations and 
constant threat to life; (e.g. unstable angina, poorly controlled COPD, 
symptomatic CHF, recent (less than three months ago) myocardial infarction 
or stroke. 
ASA 5 A moribund patient, not expected to survive beyond 24 hours without surgery; 
(e.g. ruptured abdominal aortic aneurysm, massive trauma, and extensive 
intracranial haemorrhage with mass effect). 
ASA 6 A brain-dead patient whose organs are being removed with the intention of 
transplanting them into another patient 
 
STUDY DESIGN AND OUTCOME MEASURES 
-Study I 
In this cohort study, data was obtained from 23 hospitals using the Orbit surgical planning 
system software, which covers approximately 40% of Sweden. Patients >18 years, 
undergoing non-cardiac surgery between January 1, 2007, and December 31, 2014, were 
included. To acquire information on discharge dates, covariates and drug exposure, surgical 
records were linked to the National Patient Register, the Swedish Prescribed Drug Register 
and Swedish Cause of Death Registry using the personal identification number assigned to all 
at birth or at immigration. Exclusion criteria were; ambulatory care surgery, cardiac-, 
obstetric- and minor surgery, surgeries performed before 2007 or after 2014, and if a valid 
surgery code in Orbit – or a corresponding surgery code in NPR – was lacking. Data 
collection included individual-level information of demographics and medical history; age, 
sex, geographic region of residence, ASA-classification, hospital diagnoses and dispensed 
drug prescriptions within five years of surgery. This made it possible to identify 
comorbidities in patients treated in outpatient care, to validate preoperative hospital diagnoses 
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and calculation of Charlson comorbidity index.69 Statistics of the incidence of acute MI per 
100 000 inhabitants by year, age and geographical were extracted from the NBHW statistical 
database70 and used to calculate standardized incidence ratios (SIR). 
Perioperative characteristics included date, type and duration of surgery. Based on surgical 
codes, procedures were clustered into 13 subtypes: gastrointestinal, endocrine, ophthalmic, 
ENT, dental, thoracic, neuro, breast, urologic, gynaecologic, orthopaedic, vascular and 
dermatologic surgery. To identify all cases of myocardial infarctions <30 days after surgery, 
both Swedeheart and NPR was used. The cohort inclusion and exclusion procedure is detailed 
in the participant flowchart, Figure 3. 
Main exposure was surgical procedures requiring anaesthesia and in-hospital care. 
Primary outcome was incidence of MI, fulfilling the universal criteria,16 diagnosed within 30 
days after surgery. Secondary endpoints sought to illuminate characteristics and predictors of 
perioperative MI, to evaluate if major non-cardiac surgery increases risk of MI compared 
to matched non-hospitalized controls and to report associations with short- and long-term 
mortality. 
Study II  
An observational cohort study of all adult patients undergoing major elective non-cardiac 
surgery at Karolinska University Hospital, Stockholm, Sweden, from October 2012 to May 
2013, who, in advance, were planned for an overnight admission at the postoperative unit. 
Patients undergoing pheochromocytoma surgery were excluded. Preoperative risk factors 
(comorbidities), intraoperative events (hypotension, tachycardia and hypoxia) and 
postoperative data (blood loss and fluid balance) were collected from medical records. Levels 
of high sensitivity cardiac Troponin T (hs-cTnT) were measured on postoperative day 1. 
Myocardial damage was defined as an increase in the hs-cTnT value above 14 ng/L. Cases of 
MI within 30 days of surgery were adjucated by a cardiologist. 
Main exposure was intraoperative hypotension, defined as a percentage decrease in SBP 
relative each patient's baseline, lasting >5 minutes. Baseline BP was determined as the 
patient’s habitual value measured as an estimate of all BPs, documented within two months 
prior to surgery, obtained from the surgical ward, preoperative anaesthetic consultation or 




Primary outcome was perioperative myocardial damage, defined as elevated hs-cTnT >14 
ng/L on postoperative day one. Secondary outcomes were MI, defined according to the fourth 
universal definition,16 and 30-day mortality. 
Study III 
An observational cohort study of adult patients undergoing major elective non-cardiac 
surgery at Karolinska University Hospital, Stockholm, Sweden, from Oct 2012 to May 2013 
and Jan 2015 to April 2016, who, in advance, were planned for an overnight admission at the 
postoperative unit. Preoperative risk factors (comorbidities), intraoperative events and 
postoperative data were collected from medical records. Plasma creatinine were measured 
before, on the first, second and third day after surgery. 
Main exposure was intraoperative hypotension, defined as a percentage decrease in SBP 
relative each patient's baseline, lasting >5 minutes. Baseline BP was determined as the 
patient’s habitual value measured as an estimate of all BPs, documented within two months 
prior to surgery, obtained from the surgical ward, preoperative anaesthetic consultation or 
documentations from the primary health care. 
Primary outcome was AKI stage 1, or higher, within the first two postoperative days, 
determined according to the KDIGO criteria.33 Secondary outcomes were to study the impact 
of other potential risk factors including; comorbidities, blood loss and fluid overload.  
Study IV 
A nested case-control study of patients developing MI within 30 days of surgery, matched 
with non-MI-patients from the same source population, the cohort in study I. Study 
participants were adults undergoing non-cardiac surgery at 3 hospitals in Sweden; 
Karolinska, Lund, and Malmö university hospital, from 2007 to 2014. Control subjects were 
sampled among patients alive and without MI diagnosis at day 30, i.e. cumulative incidence 
sampling.71 Matching criteria were: age, sex, ASA-class, cardiovascular disease, hospital, 
year-, type- and extent of surgical procedure. Matching variables were selected based on risk 
factors of MI identified in study I, except hospital, which was chosen for convenience. 
Regarding 10% of the sampled cases, an exact matched control could not be identified and 
matching on calendar year and knife-time was relaxed, resulting in a slight imbalance on 
these factors.  Description of the source population and the selection of cases and controls is 
detailed in Figure 4, Flowchart. Medical records were reviewed to validate MI diagnoses and 
retrieve information on comorbid history, baseline BP and laboratory values. Intraoperative 
data were collected from anaesthetic charts. 
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Main exposure was intraoperative hypotension (IOH), defined as at least one event of an 
absolute decrease in SBP, from patient preoperative baseline, lasting >5 minutes. Baseline BP 
was determined as the patient’s habitual value measured as an estimate of all BPs, 
documented within two months prior to surgery, obtained from the surgical ward, 
preoperative anaesthetic consultation or documentations from the primary health care. IOH 
was categorized into quartiles in accordance with incidence among controls; <20 mmHg, 21-
40 mmHg, 41-50 mmHg or >50 mmHg drop from individual baseline. Notably, different 
definitions of IOH was further analysed, including a comparison between absolute thresholds 
and relative decreases from baseline, detailed under statistics. 
Primary outcome was to evaluate the effect of IOH on acute perioperative MI, fulfilling the 
universal criteria,16 occurring within 30 days of surgery. Secondary outcomes were frequency 
of MI type 1 vs type 2, postoperative day of MI and mortality beyond 30 days among case- 
and control-patients. 
 
Table 4. Summary of studies I-IV 
Study I II III IV 
Study design Multicenter, cohort Cohort Cohort Nested case control 


































Sample size 400 742 300 470 Cases: 326 
Controls: 326 
Study period 2007-2014 2012-2013 2012-2013 
2015-2016 
2007-2014 








MI <30 days of 
surgery 
Hs-cTnT >14 ng/L 
(myocardial damage) 
AKI IOH as risk factor of 
perioperative MI  
     
AKI = Acute Kidney Injury, IOH = Intraoperative hypotension, MI = Myocardial infarction, NBHW = National 





Figure 3. Participant Flowchart, study I. 
 
 





Total Number of Surgeries in Orbit, n=1 125 434*
Excluding:
• < 30 days of follow up, n=35,398
• Surgery codes starting with U,V,X,Y,Z, n=76,016
• Not a valid surgery code in Orbit, n=91,300
• No corresponding surgery code in NPR, n=122,782
• Year < 2007, n=260 719
Remaining, n=539 219
*Surgeries in ambulatory care and individuals <18 years old excluded
Remaining, n=400 742 
Excluding:
• Cardiac surgery, n=17 959
• Obstetric surgery, n=47 481
• Minor surgical procedures, n=8578
Remaining, n=465 201
Excluding
• Skellefteå hospital, n=5082
• ASA missing; Year 2007 (n=19 553), Huddinge Hospital (n=37 982) and 
Landskrona Hospital (n=1842) à n(total)=59 377
Total Number of Surgeries at 3 centers:
• Karolinska University Hospital (KS): 91 318
• Lund University Hospital (USIL): 22 612 
• Malmö University Hospital (MAS): 54 302
Excluding:
• Patients with missing ASA 
classification: n=15 081
• Minor surgical procedures: n=1662
*No myocardial infarction (MI),  recent MI <30 days preoperatively or >30 
days after surgery, cardiac surgery or no surgery.
Excluding:
• Intraoperative data 
unavailable, n=2






Total Number of Surgeries in a cohort
of non-cardiac surgical patients sampled












• MAS, n=232 Excluding:
• No MI*, n=127
• Intraoperative data 
unavailable, n=52













Data was analysed using STATA version 14.2 (Stata Corp., College Station, TX, USA). In 
general, all statistical analysis followed a pre-set analysis plan according to the priori defined 
hypotheses. Continuous variables are presented as medians with interquartile range (IQR) and 
categorical variables as percentages. For comparison of continuous data, the Mann–Whitney 
U-test or Kruskal-Wallis test was used, binary variables were compared using the χ2 test. 
Statistical tests are two-sided and p-values below 0.05 considered to be significant. In the 
multivariable analyses, covariates were considered as potential confounders based on clinical 
perspective, results in the bivariate analyses, and on whether the addition to the multivariable 
models changed the relative risk estimates. Directed acyclic graphs (DAGs) were used to 
assess the association between covariates and the relation to exposures and outcomes, in 
order to evaluate, and differentiate, between confounding and effect modification. Sensitivity 
analyses and tests for interaction were performed, in all studies, to test the robustness of the 
results.  
-Study I 
In the multivariable analyses, logistic regression was used to analyse the association between 
risk factors and MI development, results presented as odds ratios (OR) with 95% CI. The 
relative risk of MI after different surgical procedures were calculated and the surgeries were 
divided into three risk groups; low (endocrine, ENT, ophthalmic dental, breast and 
gynaecological surgery), medium (GI, neuro, urologic, orthopaedic and dermatologic surgery) 
and high (vascular and thoracic surgery) risk surgery, based on odds ratios (OR). The 
following risk factors were entered into the model; age (six categories), sex, ASA-
classification, cardiovascular- renal-, cerebrovascular- and pulmonary comorbidity, diabetes 
mellitus (DM), Charlson comorbidity score, surgical risk group and year. The risk factors 
found in the multivariable model indicated that MI-risk varied substantially between 
individuals. To illustrate risk differences, the cohort was divided into different strata using 
significant parameters to create quantiles. Absolute risk measures were calculated in these 
five risk groups. Mortality after postoperative day 30 was compared with stratified Cox’ 
regression, crude and adjusted hazard ratios (HR) with 95% CI are presented. Standardized 
incidence ratios (SIR) were calculated as the ratio of the observed and expected number of 
cases using direct standardisation method. The expected number of cases was calculated 
according to the yearly incidence rate for all individuals in the statistical database provided by 
the National Board of Health and Welfare. The SIRs were standardized by 5-year age group, 
sex, 1-year time period and geographic region. 95% confidence intervals (CIs) were 
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produced. Sensitivity analyses and tests for interaction were performed. Most importantly to 
evaluate if missing information of ASA-classification was associated with systematic errors. 
There were no significant differences when patients with missing ASA were analysed 
separately. Restriction of these surgeries, or hospitals with high percentage of missing ASA-
information, had no impact on crude or adjusted relative risks in the remaining cohort. All 
indicating that ASA-classification were missing completely at random. Moreover, the 
percentage of patients with missing ASA- was below 10%: no imputation of data was 
considered needed.  Further analyses, adjusting for time trends and potential clustering by 
centre, and restriction of the cohort by age, were conducted.  
Study II & III 
Logistic regression was used to analyse the association between intraoperative hypotensive 
events and perioperative hs-cTnT elevation (study II) and AKI development (study III), 
results presented as odds ratios (OR) with 95% CI. The final models included the following 
significant adjustment variables: age, preoperative creatinine, abnormal ECG, ASA>2, and 
congestive heart failure (study II) and male sex, ASA>2, preoperative creatinine, treated 
hypertension and FLB (study III). In study II, patients were divided into tertiles reflecting 
underlying risk, using the significant parameters, in order to analyse the effect of hypotension 
in different risk strata. In study III, the influence of preoperative high creatinine, 
intraoperative blood loss and fluid balance on the association between a hypotensive event 
and AKI was further explored, and tests of interaction between IOH and pre-existing 
hypertension evaluated. 
Study IV 
Conditional logistic regression was used in the multivariable analysis to assess the association 
between predefined risk covariates and perioperative MI development in cases and controls, 
results presented as odds ratios (OR) with 95% CI. Preoperative, unmatched, risk factors; 
preoperative BP, DM and IHD (since there were remaining significant incidence difference 
between cases and controls) and intraoperative risk factors; blood loss, low Hb-value and 
fluid balance, were entered into the model. Three definitions of the main exposure, IOH, were 
explored; relative to baseline (mmHg), relative to baseline (%) and absolute intraoperative 
thresholds. All three definitions were subdivided into 4 categories, in accordance with 
incidence among controls. The multivariable models yielded were compared using Akaike 
information criterion (AIC) test. The population attributable fractions (PAFs), the proportion 
(fraction) of all cases in the population that can be attributed to the exposure, were calculated 
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using information of the proportion of exposed subjects in the entire surgical population and 
the relative risks. 
To illustrate the overall low absolute risks, cases and controls were distributed to different 
risk strata, according to five risk-groups created in the original Orbit cohort, used in study I; 
very low (1)-, low (2)-, median (3)-, high (4)-, and very high (5) risk-group. Absolute risks in 
these risk-groups in relation to hypotensive events were calculated using absolute risks of MI 
in study I and the relative risks associated with IOH in this study. These calculations rely on 
the assumption that the estimated odds ratios apply to the source population, the study I 
cohort, and that the estimated incidence of IOH events among our sampled controls estimates 
of the corresponding incidence in the whole cohort. 
Controls were selected using cumulative incidence sampling,71 all controls were bound to be 
alive at 30 days, thus differences in 30-day mortality between cases and controls could not be 
assessed. Mortality from day 31-90 and day 91-365 was compared with stratified Cox’ 
regression, crude and adjusted hazard ratios (HR) with 95% CI are presented. The IOH 
related risk of fatal MI within 30 days, among cases, was analysed with logistic regression, as 
were the association with MI type 1 and 2. We assessed possible effect modification by 
preoperative BP, risk group, day of MI and tachycardia. Internal stratified analyses of 
preoperative BP, postoperative day of MI diagnose, risk group and tachycardia were 














Chapter 3. Results 
STUDY I 
The final surgical cohort consisted of 400 742 patients, participant characteristics presented in 
table 5. The number of patients suffering MI <30 days of surgery was 1605 (0.41%). 
Multivariable logistic regression identidfied risk elevation associated with increasing age, 
surgical procedure, and preoperative cardiovascular comorbidity (Table 6). ASA-
classification excelled as an independent risk predictor, reflecting how combinations of risk 
factors result in extensive risk elevation of MI and mortality.  
 









































Risk factor OR (Unadjusted) OR (Adjusted*) 
Non-elective 3.15 (2.84-3.51) 1.75 (1.55-1.97) 
Male 1.35 (1.22-1.50) 1.13 (1.02-1.27) 
Age, y  <65 





         70-74 4.78 (3.83-5.97) 2.22 (1.76-2.79) 
         75-79 
         80-84 








         2 
         3 









Cardiovascular† Disease, No ref ref 
                                       Yes, excl MI 





Renal‡ Disease 2.67 (2.29-3.13) 1.05 (0.89-1.24) 
Cerebrovascular§ Disease 2.86 (2.46-3.32) 0.97 (0.83-1.13) 
Pulmonary|| Disease 2.88 (2.52-3.29) 1.00 (0.87-1.16) 
Diabetes 2.68 (2.38-3.02) 1.28 (1.13-1.46) 
Charlson score:   0 
                            1 







Surgery:  Low1 Risk ref ref 
               Medium2 Risk 6.66 (5.04-8.79) 2.22 (1.66-2.96) 
                High3 Risk 16.8 (12.4-22.7) 4.40 (3.21-6.02) 
Year:      2013-2014 ref  
               2011-2012 1.14 (0.99-1.31) 1.19 (1.04-1.37) 
               2009-2010 1.13 (0.97-1.31) 1.29 (1.11-1.50) 
               2007-2008 1.44 (1.24-1.67) 1.88 (1.62-2.19) 
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Type of Surgery Elective 
Acute  
281 507 (70) 




Gender  Female 
Male 
220 434 (55) 




ASA 1 96 583 (24) 22 (0.02) <0.001 
 2 159 092 (40) 298 (0.19)  
 3 96 977 (24) 810 (0.84)  
 4 8038 (2) 280 (3.5)  
 Missing 40 052 (9.9) 195 (0.49)  
Age, y  64 (49, 75) 81 (72, 86) <0.001 
Age, y <65 201 500 (50) 181 (0.09) <0.001 
 65-69 49 810 (12) 131 (0.26))  
 70-74 
75-79 
44 992 (11) 






32 246 (8) 




Preoperative data Cardiovascular† Disease; 
                            yes, excl MI 
 




                             yes, incl MI 19 453 (5) 456 (2.3)  
                             no 191 309 (48 166 (0.09  
 Renal‡ Disease; yes 
                           no 





 Cerebrovascular§ Disease; yes 
                                            no 
22 787 (6) 241 (1.1) 
1364 (0.36) 
<0.001 
 Pulmonary|| Disease; yes 
                                   no 
30 545 (8) 297 (0.97) 
1308 (0.35) 
<0.001 
 Diabetes; yes 
                 no 





 Charlson score    0 
                            1 
                          ≥2 
198 082 (49) 
38 617 (10) 





Perioperative data Knife time ≥2h 
                  <2h 





Surgery Low risk1 87 141 (22) 69 (0.08) <0.001 
 Medium risk2 291 505 (73) 1284 (0.44)  
 High risk3 22 096 (6) 252 (1.14)  




71 377 (18) 
90 635 (23) 
111 929 (28) 






Mortality 30-day; Dead 
             Alive 
90-day; Dead 
             Alive 
1-year; Dead 
            Alive 
7152 (1.8) 
 
13 818 (3.5) 
 












     
* Percentage of MI<30d within the horizontal subpopulation of the cohort. 
† Chronic ischemic heart disease, Angina pectoris, Hypertensive disease, Cardiac arrest, Heart failure, 
Cardiomyopathy, Conduction disorders/Cardiac arrhythmias, Diseases of arteries, arterioles and capillaries. 
‡ Acute renal failure/unspecified renal failure, Chronic renal failure, Other renal disease 
§ Cerebrovascular disease 
|| Pneumonia, COPD 
1) Endocrine, ENT, ophthalmic, dental, breast, gynaecologic surgery 
2) GI, neuro, urologic, orthopaedic, dermatologic surgery 





As detailed in methods, patients were divided into five equally sized groups based on risk, 
incidences per 1000 surgeries are illustrated in table 7 and figure 5. A small subset, consisting 
of high-risk patients, were found to be the main drivers of perioperative cardiac morbidity. 
Among two thirds of the cohort, perioperative MI is infrequent, less than 1 in 1000, and 75% 
of the events occur in one fifth. 
 








1. Very low risk: Age<65 y, ASA 1, low risk surgery, no cardiovascular comorbidity or diabetes. 
2. Low risk: Same as risk group 1, but with 2 or 3 factors described in risk group 3 below. 
3. Medium risk: Age 65-79 y, ASA 2, medium risk surgery, cardiovascular comorbidity without 
previous MI, diabetes. 
4. High risk: Same as risk group 3 but with 2 or 3 factors described in risk group 5 below. 

















 OR (95% CI) Inc/1000 (95% CI) 
1. Very Low  77 628 (22) 5 (0.0064)  Ref 0.064 (0.02-0.12)  
2. Low  75 348 (21) 31 (0.041)  6.39 (2.48-16.4) 0.41 (0.27-0.56)  
3. Medium  77 132 (21) 85 (0.11)  17.1 (6.95-42.2) 1.10 (0.87-1.34)  
4. High  63 178 (18) 223 (0.35)  55.0 (22.7-133) 3.53 (3.07-3.99)  
5. Very High  67 404 (19) 1066 (1.58)  249 (104-601) 15.8 (14.9-16.8)  
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Compared to the Swedish population risk increase was five-fold, standardized by age, sex, 
geographical region and year (Table 8). There were correlations with short- and long-term 
mortality; 5-fold increased 30-day mortality, doubled risk at 3 months and 30% risk-increase 
remaining one year after surgery (Table 9). 
 












Table 9. Mortality rates in patients developing MI within 30 days after surgery; Odds ratios presented for 30-day 
mortality, Hazard ratios presented for mortality day 31-90 and day 91-365 after surgery. 
* Adjusted for 5-year age group, gender, ASA-class, cardiovascular disease, previous MI, renal- 
cerebrovascular- and pulmonary disease, diabetes, Charlson comorbidity index, surgical risk group, acute vs 



















Total  1605 5.35 (5.09-5.61) 401 75 
Female  763 6.06 (5.63-6.49) 190 31 
Male  842 4.83 (4.51-5.17) 210 43 










Mortality <30 Days 22.2 (19.7-25.1) 5.49 (4.76-6.32)   
 Day 31-90   8.03 (6.72-9.58) 2.05 (1.72-2.46) 
 Day 91-365   4.29 (3.63-5.06) 1.37 (1.16-1.62) 




Of the final cohort of 300 patients, 90 (30%) had elevated levels of hs-cTnT on the first 
postoperative morning, as an indication of myocardial damage. Baseline and perioperative 
characteristics of patients are presented in table 10. For the entire cohort, average age was 67 
years and 53% were women. The most common surgery was gastrointestinal surgery (40%), 
followed by urological (29%) and gynaecological (17%) surgery. Patients with elevated 
levels of hs-cTnT on postoperative day 1 were older with more cardiovascular risk factors, 
one third of had an abnormal preoperative ECG, compared to 8% with normal hs-cTnT levels 
(p <0.001). More than twice as many, 38% vs 17%, had chronic treatment with beta blockers 
(p<0.001). Moreover, they had more intraoperative adverse events and worse outcome, with 
significantly more MI’s. 
Intraoperative hypotension, defined as a fall in systolic blood pressure >50% from baseline 
for >5 min, was associated with high troponin values on the first postoperative day    (OR, 
4.4; 95% CI 1.8-11.1). As patients were divided into three equally sized groups based on risk 
estimates; low risk-, median- and high-risk group, the risk of hs-cTnT elevation after surgery 
increased considerably in the presence of an intraoperative hypotensive event in all three risk 














Table 10. Characteristics of the cohort and the proportion of myocardial damage (injury), defined as hs-
cTnT>14 ng/l, on postoperative day 1. 











 Age  67 (57, 74) 63 (54, 70) 73 (67, 78) 0.0000 
Gender n(%) Female 159 (53) 119 (57) 40 (44) 0.052 
 BMI 26 (23, 29) 26 (23, 28) 25 (22, 29) 0.61 
 Smokers 45 (15) 34 (16) 11 (12) 0.38 
ASA 1 31 (10) 26 (12) 5 (6) 0.075 
 2 138 (46) 111 (53) 27 (30) 0.000 
 3 130 (43) 72 (34) 58 (64) 0.000 
 4 1 (0.3) 1 (0.5) 0 0.000 
Comorbidity Hypertension 128 (43) 75 (36) 53 (59) 0.000 
 Atrial fibrillation 23 (7.7) 8 (4) 15 (17) 0.000 
 Congestive heart failure 9 (3) 2 (1) 7 (8) 0.001 
 Ischemic heart disease 26 (9) 12 (6) 14 (16) 0.005 
 Insulin-dependent 
diabetes mellitus 
23 (8) 12 (6) 11 (12) 0.052 
Chronic medication ACE inhibitors 42 (14) 27 (13) 15 (17) 0.38 
 Beta blockers 69 (23) 35 (17) 34 (38) 0.000 
 Calcium channel 
blockers 
39 (13) 22 (10) 17 (19) 0.047 
Preoperative data Creatinine (µmol/L) 71 (60, 87) 68 (59, 79) 86 (65, 103) 0.0000 
 Abnormal ECG 45 (15) 29 (8) 16 (32) 0.0000 
Surgical procedure Gastrointestinal surgery 121 (40) 82 (39) 39 (43) 0.49 
 Urology 87 (29) 62 (30) 25 (28) 0.76 
 Gynecology 50 (17) 36 (17) 14 (16) 0.74 
 Vascular surgery 8 (3) 2 (1) 6 (7) 0.005 
 Plastic surgery 6 (2) 5 (2) 1 (1) 0.47 
 Head- and neck 
surgery 
21 (7) 18 (9) 3 (3) 0.10 
 Orthopedics 7 (2,3) 5 (2) 2 (2) 0.93 
Type of anesthesia General 
Regional 


















Intraoperative events Hypotension 43 (38, 48) 42 (38, 46) 46 (39, 50) 0.0004 
 Hypotension >40% 190 (63) 126 (60) 64 (71) 0.067 
 Hypotension >50% 34 (12) 13 (6) 21 (23) 0.000 
 Tachycardia 33 (11) 21 (10) 12 (13) 0.40 
 Hypoxia 2 (0,68) 0 2 (2) 0.029 









 Intraoperative blood loss 
(%) 
11 (5, 27) 10 (4, 27) 12 (6, 27) 0.15 







 AKI 69 (23) 42 (20) 27 (30) 0.059 
Outcome MI <30 days 15 (5) 4 (2) 11 (12) 0.0000 
 Mortality <30 days 5 (1.7) 2 (1.0) 3 (3.3) 0.14 
 Mortality <6 month 12 (4) 6 (2.9) 6 (6.7) 0.12 
BMI – body mass index, ECG – electrocardiography, Hs-cTnT – high sensitivity cardiac troponin T, 
AKI – acute kidney injury, ASA - the American Society of Anesthesiologists physical status 






Table 11. Risk estimates in combination with intraoperative hypotensive event* and the effect on myocardial 
damage (hs-cTnT >14 ng/l). 
Risk group Hypotensive event Hs-cTnT >14 ng/l Total RR 
No (n=210) Yes (n=90) n=300 
Low† No 100 (94) 6 (6) 106  
4.8 Yes 5 (71) 2 (29) 7 
Medium‡ No 61 (76) 19 (24) 80  
2.6 Yes 3 (38) 5 (63) 8 
High§ No 36 (45) 44 (55) 80  
1.3 Yes 5 (26) 13 (74) 19 
* Decrease in systolic arterial pressure >50% relative to baseline for >5 min 
Low risk† (1/3) = no risk factor or only; abnormal ECG or ASA >2 or preop creatinine <59 µmol/L 
Medium risk‡ (1/3) = only age >70 y and/or preop creatinine ≥79 µmol/L; combinations of two risk factors: 
ASA >2 and (preop creatinine <59 µmol/L or >79 µmol/L or age 70-79 y or abnormal ECG) or 
preop creatinine <59 µmol/L and abnormal ECG 
High risk§ (1/3) = remaining combinations 
 
 
Figure 6.  
 
* Decrease in systolic arterial pressure >50% relative to baseline for >5 min 
Low risk† (1/3) = no risk factor or only; abnormal ECG or ASA >2 or preop creatinine <59 µmol/L 
Medium risk‡ (1/3) = only age >70 y and/or preop creatinine ≥79 µmol/L; combinations of two risk factors: 
ASA >2 and (preop creatinine <59 µmol/L or >79 µmol/L or age 70-79 y or abnormal ECG) or 
preop creatinine <59 µmol/L and abnormal ECG 





Within 30 days of surgery, 15 patients (5%) developed MI, two thirds had their MI diagnosed 
within the first 4 postoperative days and the majority (87%) within a week. Of all 300 
patients, 34 (12%) had an intraoperative fall in SBP of more than 50% from baseline, 21 of 
those had myocardial damage and 8 patients were diagnosed with perioperative MI (p 
<0.001). The relation between the combination of a hypotensive event, hs-cTnT elevation and 
myocardial infarction is presented in table 12. The combination of several factors lead to a 
higher likelihood of the event, indicating a 24 % MI incidence as compared to 0.5% with and 
without the aforementioned risk factors. 
 
Table 12. Association between the combination of hypotensive event*, myocardial damage (hs-cTnT >14 ng/l) 
and MI <30 days. 
Hypotensive event Hs-cTnT >14 ng MI <30 days Total 
No (n=285) Yes (n=15) n=300 
No No 196 (99.5) 1 (0.5) 197 
No Yes 63 (91) 6 (9) 69 
Yes No 10 (77) 3 (23) 13 
Yes Yes 16 (76) 5 (24) 21 


















During the study time frame a total of 470 patients fulfilled the inclusion criteria in this 
observational cohort study of high risk elective non-cardiac surgerical patients. 127 patients, 
or 27%, developed AKI within two days of surgery. A number of unalterable characteristics, 
such as male gender, preoperative creatinine elevation, treated hypertension and ASA-class 
>2 were associated with risk of AKI. Baseline characteristics of the study cohort are shown  
in table 13 and results from the multivariable logistic regresssion are presented in table 14. 
An intraoperative hypotensive event, defined by a 40% and 50% drop from SBP baseline for 
a minimum of five minutes, using each patient as control, was associated with an elevated 
risk of AKI, even after adjustment of aforementioned characteristics. Further adjustment for 
blood loss in quartiles, as detailed in table 15, had no considerate effect on the association. 
 
As preoperative creatinine was associated with elevated risk of AKI, sensitivity analysis was 
performed with restriction of patients in the quartile with highest preoperative creatinine. This 
yielded an OR of 2.85 (95% CI 1.31 to 6.23), as shown in table 15, indicating a more 
pronounced effect of an intraoperative hypotensive event on AKI risk in patients without 
lowered glomerular filtration rate. This was strengthened in a further interaction analysis 
illustrating a clear risk gradient of AKI in the presence of an increasing hypotensive event 
when creatinine was <90 µmol/L, but among patients with preoperative creatinine >90 
µmol/L, there was a consistently high risk, with or without a hypotensive event, but no 
gradient.  
Table 14. Preoperative predictors and odds ratios of AKI in relation to an intraoperative hypotensive event* and 
the influence of intraoperative blood loss. 
  
*Decrease in systolic blood pressure in percent relative to baseline for >5 min. 
†Adjusted for the covariates: gender (male), ASA>2, treated hypertension, pre-operative creatinine >90 µmol/L. 
‡Adjusted for the covariates mentioned above and blood loss in quartiles. 
 
Table 15. Sensitivity analyses of the association hypotensive event and AKI; restriction of the cohort, excluding 







*Decrease in systolic blood pressure in percent relative to baseline for >5 min. 
†Adjusted for the covariates: gender (male), ASA>2 and treated hypertension. 







(>40-≤50%) vs ≤40% 
Hypotensive event* 










Risk faktor OR† (95% CI) 
Hypotensive event* 
(>40-≤50%) vs ≤40% 
Hypotensive event* 






Table 13 – Baseline characteristics of the cohort in study III and the proportion of AKI. 









 Age  67 (58 to 74) 67 (58 to 75) 67 (58 to 73) 0.54 
Sex n(%) Female 223 (47) 180 (52) 43 (34) 0.000 
 BMI 25 (23 to 28) 25 (23 to 28) 26 (23 to 29) 0.086 
 Smokers 60 (13) 39 (11) 21 (17) 0.14 
ASA 1 47 (10) 34 (10) 13 (10) 0.92 
 2 221 (45) 166 (48) 45 (35) 0.012 
 3 208 (44) 141 (41) 67 (53) 0.024 
 4 4 (0.009) 2 (0.06) 2 (0.02) 0.060 
 >2 212 (45) 143 (42) 69 (54) 0.014 
Comorbidity Hypertension 206 (44) 137 (40) 69 (54) 0.005 
 Atrial fibrillation 43 (9) 29 (8) 14 (11) 0.39 
 Congestive heart failure 19 (4) 14 (4) 5 (4) 0.94 
 Ischemic heart disease 38 (8) 25 (7) 13 (10) 0.30 
 Insulin-dependent diabetes 
mellitus 
29 (6) 18 (5) 11 (9) 0.17 
Chronic medication ACE inhibitors 71 (15) 45 (13) 26 (20) 0.048 
 Beta blockers 115 (24) 74 (22) 41 (32) 0.016 
 Calcium channel blockers 70 (15) 40 (12) 30 (24) 0.001 
Preoperative data Creatinine (µmol/L) 75 (62 to 91) 73 (61 to 89) 81 (67 to 100) 0.0033 
Surgical procedure Gastrointestinal surgery 238 (51) 165 (48) 73 (57) 0.071 
 Urology 136 (29) 96 (28) 40 (31) 0.46 
 Gynaecology 54 (11) 44 (13) 10 (8) 0.14 
 Vascular surgery 8 (2) 5 (1) 3 (2) 0.50 
 Plastic surgery 6 (1) 6 (2) 0 0.13 
 Head- and neck 
surgery 
21 (4) 20 (6) 1 (1) 0.02 
 Orthopaedics 7 (1) 7 (2) 0 0.11 
Type of anaesthesia General 
Regional 













Intraoperative events Hypotension* 43 (37 to 48) 43 (38 to 50) 42 (36 to 47) 0.012 
 Hypotension >40% * 286 (61) 197 (57) 89 (70) 0.013 
 Hypotension >50% * 68 (14) 42 (12) 26 (20) 0.024 
 Tachycardia 50 (10) 36 (10) 14 (11) 0.87 
 Hypoxia 4 (0.009) 3 0.009) 1 (0.008) 0.93 
 Intraoperative blood loss 
(ml) 
500 (200 to 
1200) 
400 (150 to 
1095) 
800 (300 to 
1800) 
0.0001 




3123 (2364 to 
4178) 
0.0002 
 Hs-cTnT 11 (7 to 17) 10 (6 to 16) 14 (9 to 21) 0.0000 
Outcome Myocardial injury** 156 (33) 98 (29) 58 (46) 0.000  
Mortality <30 days 9 (2) 4 (1) 5 (4) 0.0046 
 
 
    
BMI – body mass index (kg/m2), ECG – electrocardiography, Hs-cTnT – high sensitivity cardiac troponin T, 
AKI – acute kidney injury, ASA - the American Society of Anesthesiologists physical status 
* Decrease in systolic blood pressure relative to baseline; % from baseline, 40 and 50% respectively. 











In this case-control study, nested within a well-defined large cohort of high-risk patients 
undergoing non-cardiac surgery, 326 cases met the inclusion criteria and were successfully 
matched with 326 controls (see Flowchart, Fig 4 for details in the selection process). 
Conditional logistic regression identified IOH as an important risk factor for MI-development 
<30 days of surgery (table 16, Fig 7). An intraoperative hypotensive reduction of 41-50 
mmHg, from individual baseline SAP, was associated with a more than tripled MI risk, OR 
3.42 (95% CI, 1.13 to 10.3), and a hypotensive event >50 mmHg with a considerable risk 
increase, OR 22.6, (95% CI, 7.69 to 66.2). These risk estimates are derived after adjustment 
for preoperative covariates, high BP (SAP ≥140 mmHg), DM, and IHD and intraoperative 
risk events; blood loss (>1800 mL), Hb <85 g/L, hypoxia (SaO2 <90%) and fluid balance 
(>2000 mL). The absolute decrease in mmHg, from individual preoperative BP baseline, was 
selected as main IOH definition. Multivariable comparison of the three final models based on 
different IOH definitions yielded similar odds estimates. The AIC test favoured the models 
with IOH defined as a relative to baseline measure, ahead of the model with absolute blood 
pressure thresholds (AIC value 226), while data do not clearly support a discrimination 
between the models based on absolute and relative change from baseline blood pressure (AIC 
value 214 vs 210), results shown in table 17. 
 
Table 16. Odds ratios of MI in relation to intraoperative hypotension. 
* Decrease in SBP from baseline for >5 min 
† Adjusted for preoperative risk factors; IHD and DM 
‡ Further adjusted for intraoperative risk factors; blood loss (>1800 mL), Hb <85 g/L, hypoxia (SaO2 <90%) and 























Hypotensive event*   ≤20 13 (4) 84 (26) ref ref ref 
 (mmHg)                    21-40 22 (7) 105 (32) 1.53 (0.60-3.94) 1.37 (0.50-3.73) 1.37 (0.48-3.92) 
                                   41-50  31 (10) 64 (19) 5.30 (1.87-15.1) 4.58 (1.60-13.1) 3.42 (1.13-10.3) 
                                    >50 260 (80) 73 (22) 38.8 (14.5-104) 27.0 (9.82-74.1) 22.6 (7.69-66.2) 
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Figure 7. Odds ratios (log scale) of MI in relation to intraoperative hypotension. 
 
* Decrease in SBP (mmHg) from baseline for >5 min 
† Adjusted for preoperative risk factors; SBP, IHD and DM 
‡ Further adjusted for intraoperative risk factors; blood loss (>1800 mL), Hb <85 g/L, hypoxia (SaO2 <90%) and 
fluid balance (>2000 mL) 
 
 
Table 17. Adjusted Odds ratios of MI in relation to different definitions of intraoperative hypotension, 









* Decrease in SBP from baseline for >5 min, defined as an absolute decrease (mmHg) relative to baseline; 
   ≤20, 21-40, 41-50, >50 (mmHg) 
† Decrease in SBP from baseline for >5 min, defined as a percentage decrease relative to baseline; 
   ≤20, 21-30, 31-40, >40 (%) 
‡ Decrease in SBP for >5 min, defined as absolute thresholds; 
   ≥110, 90-110, 80-90, <80 (mmHg) 











Hypotensive event      Q1 ref  ref ref 
                                    Q2 1.37 (0.48-3.92) 1.73 (0.62-4.86) 2.43 (1.11-5.31) 
                                    Q3 3.42 (1.13-10.3) 3.72 (1.41-9.83) 4.15 (1.74-9.90) 
                                    Q4 22.6 (7.69-66.2) 26.8 (9.53-75.6) 24.2 (9.08-64.3) 
AIC§ 214 210 226 
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The right panel of table 18 displays the absolute risks of MI in relation to IOH together with 
the estimated incidence of IOH in different risk groups. High absolute excess risks were 
observed among patients with a SBP drop >50 mmHg as compared to patients with a SBP 
drop ≤40 mmHg, where patients with very high baseline risk increased their risk from 3.6 to 
68 per 1000 operations, patients with high risk increased from 0.5 to 10 and the 
corresponding increase in lower risk patients was 0.1 to 1.8. We could also show that the 
incidence of high-risk hypotensive events (i.e. SBP drop>50 mmHg) decreased significantly 
with increasing risk factor burden (p=0.005). In the left panel of table 16, displaying 
published results from study I, it is shown that 19% of all non-cardiac surgeries are 
characterized by very high risk, and that 76% of MI’s occur among these patients. Overall 
PAF was 82%, hence four out of five MI’s were attributable to a serious IOH. For patients in 
the highest risk group, the associated absolute excess risk was estimated to about 6 percent. 
 
Table 18. MI risk in relation to intraoperative hypotensive events and preoperative risk group. 
* Decrease in SBP (mmHg) from baseline for >5 min 
† Data from Orbit (study I)72 
‡ Estimated from the controls in this study (P=0.005 for difference between risk groups) 
§ Population attributable fraction 
 
Risk groups 
1+2. Low risk: Age<65 y, ASA 1, low-risk surgery, no cardiovascular comorbidity or diabetes, with 2 or 3    
factors described in risk group 2 below. 
3. Medium risk: Age 65-79 y, ASA 2, medium risk surgery, cardiovascular comorbidity without previous MI, 
diabetes. 
4. High risk: Same as risk group 3 but with 2 or 3 factors described in risk group 5 below. 





  Orbit study† Case-Control study 
Risk group (1-5) No of 
operations 
(%) 





No of MI 
(%) 
MI risk per 1000 operations 





Hypotensive event*     ≤40 41-50 >50  
Relative risk (OR)     ref 2.81 18.6  
Low(1+2)+Medium(3) 230 108 (64) 121 (8) 0.8 33 10) 0.1 (38) 0.3 (23) 1.8 (38) 89 (81-94) 
High(4) 63 178 (17) 223 (16) 3.5 48 (15) 0.5 (49) 1.5 (20) 10 (31) 84 (75-90) 
Very High(5) 67 404 (19) 1066 (76) 15.8 245 (75) 3.6 (64) 10 (19) 68 (17) 80 (74-85) 
Overall PAF§        82 (75-87) 
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In table 19, results from mortality analyses are presented. At 30 days postoperatively, 88 of 
326 (27%) cases were deceased. There was no difference in IOH occurrence among patients 
with fatal (<30 days) and non-fatal MI, adjusting for age, sex, ASA-class and comorbidities 
in logistic regression (p=0.84). Day 91-365, 39 cases (20%) and 25 controls (9%) died. Crude 
HR was 2.12 (95% CI, 1.27 to 3.55), adjustment for DM and IHD resulted a HR of 2.01 
(95% CI, 1.19 to 3.38). During 31 to 90 days, there was no difference in mortality between 
cases and controls. 
Table 19. Mortality rates in patients developing MI <30 days after surgery; Hazard ratios presented for mortality 
day 31-90 and day 91-365 after surgery. 
* Data from study I. OR adjusted for 5-year age group, gender, ASA-class, cardiovascular disease, previous MI, 
renal- cerebrovascular- and pulmonary disease, diabetes, Charlson comorbidity index, surgical risk group, acute 
vs elective status and year of surgery. 
†Adjusted for diabetes and ischemic heart disease. 
 
Results yielded from the sensitivity analyses are detailed in table 20. There was no evidence 
of effect modification between preoperative BP or intraoperative tachycardia and IOH. 
Although not significant, a more pronounced effect of IOH in higher risk-patients compared 
to lower risk-patients was observed, as in MI development on postoperative day 1 to 2 










<30 Days* 88 (27) N/A 5.49 (4.76-6.32)    
Day 31-90 17 (7) 18 (8)  1.14 (0.57-2.29) 1.02 (0.47-2.19)  
Day 91-365 39 (20) 25 (9)  2.12 (1.27-3.55) 2.01 (1.19-3.38)  
















* Decrease in SBP, defined as an absolute decrease (mmHg) relative to baseline, for >5 min 
† Stratified by preoperative BP (<140 mmHg vs ≥140 mmHg) 
‡ Stratified by postoperative day of MI (day 1-2 vs > day 2) 
§ Stratified by risk group (low; risk group 1 to 3 vs high; risk group 4 to 5) 
|| Stratified by intraoperative tachycardia; >110 bpm >5 minutes 
** P-value from interaction tests
Risk factor Preoperative BP† Day of MI‡ Risk group§ Tachycardia|| 
Hypotensive 
event* 
<140 mmHg ≥140 mmHg 1-2 >2 Low High No Yes 
≤20 mmHg (ref)         
21-40 mmHg 1.12 (0.22-5.64) 1.75 (0.39-7.74) 1.77 (0.38-8.21) 1.04 (0.25-4.28) 0.53 (0.06-4.36) 1.70 (0.50-5.82) 2.68 (0.22-5.64) 0.57 (0.58-12.3) 
41-50 mmHg 3.23 (0.65-16.0) 3.60 (0.84-15.5) 4.37 (0.75-25.4) 2.89 (0. 69-12.1) 1.74 (0.26-11.8) 3.78 (0.97-14.8) 5.97 (0.65-16.0) 14.5 (1.26-28.2) 
>50 mmHg 31.9 (6.19-164) 20.9 (5.83-75.2) 43.7 (7.83-244) 13.3 (3.47-50.6) 7.08 (1.24-40.5) 38.7 (9.68-155) 47.1 (6.19-164) 52.8 (10.2-217) 
P-value** 0.74 0.62 0.47 0.42 
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Chapter 4. Discussion 
SUMMARY OF FINDINGS 
In this thesis of observational studies, risk factors of myocardial and kidney outcome in 
patients undergoing non-cardiac studies were evaluated. Overall incidence of perioperative 
MI, fulfilling the universal definition.16 was 0.41%, a small subset of high-risk patients was 
identified as the main drivers and should be targeted in order to improve perioperative 
outcomes. Compared to the Swedish population, the standardized risk increase of MI was 
five-fold and there was a strong association with short- and long-term mortality. 
Intraoperative hypotension was a major contributor to perioperative cardiac troponin 
elevation, AKI and clinically significant MI. The high absolute MI-risk associated with IOH, 
among a growing population of patients with a high risk-burden undergoing surgery, suggests 





Observational, epidemiologic studies are historically regarded as lower grade evidence in the 
methodological hierarchy of research designs.73 However, observational study designs are 
important in medical research as experimental studies not always are possible to implement, 
due to ethical reasons or clinical feasibility. Moreover, the general consensus about study 
design hierarchy, that observational studies have less validity and may overestimate causal 
relations, is challenged. Observational studies, either cohort or case-control design, if well-
performed, have been shown to yield results similar to prospective randomized trials, with 
even less heterogeneity in point estimates.74,75 
Study I is an observational descriptive cohort study with patients extracted from a nationwide 
surgical register and linked to several national and quality registries, enabling an extensive 
data collection. Study II and III are single-centre, prospective observational cohort studies 
with patients undergoing major non-cardiac surgery within a specified time-period and data 
collected from medical records and anaesthetic charts. Study IV use a nested case-control 
study design, conducted within the cohort used in study I, allowing random sampling of cases 
and controls. In cohort studies, patients are followed over time allowing frequencies and 
associations of risk factors and outcomes to be observed during this time period, an appealing 
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study design when multiple exposures and/or outcomes are evaluated. The case-control study 
design is generally preferred when rare outcomes, that develops over of long time, are 
studied, due to practical and economic reasons. In study IV, control subjects were sampled 
using the cumulative incidence (exclusive) sampling method, hence odds ratios correspond, 
on average, exactly to OR in the full cohort and would approximate risk ratio and rate ratio 
using the rare disease assumption.71 Two alternative options to sample controls in nested 
case-control studies are case-cohort (inclusive) sampling and risk-set (density) sampling. An 
important consideration is that cases and controls were sampled from a well-defined surgery 
cohort, characterized in study I. This allows estimation of the proportion of patients exposed 
to IOH events in the population, from controls, and, thus, enables a transfer of the relative 
risk to a corresponding absolute risk increase, even though this is a case-control designed 
study. An alternative approach to explore the effect of intraoperative risk factors on 
perioperative outcome, the ideal study design for providing evidence of causal relations, 
would have been a randomized controlled trial. However, from an ethical perspective, 
possible benefits yielded from the study could be outweighed by the disadvantages. To 
randomize patients to a protocolized intraoperative algorithm, in order to minimize 
hemodynamic instability, compared to standard, less careful, anaesthetic management, would 
be controversial. Even more problematic would be the difficulty of keeping the involved staff 
blinded to the purpose of the study and, by that means, the risk of Hawthorn effect76,77 
influencing the results. Also, conduction of an RCT would be time-consuming and expensive, 
and the nested case-control design was considered a fair option. 
External validity 
The meaning of external validity -  generalizability – is the possibility to draw general 
conclusions from research, i.e. to apply the results to other populations than the study sample. 
Study I was a nation-wide study, with a study cohort identified from 23 hospitals of all levels 
(university-, county and district) representing approximately 40% of Swedish hospitals. All 
adult patients undergoing various non-cardiac surgical procedures were included. 
Generalizability should be high and the possibility to make inferences regarding other 
surgical populations legitimate. The results are considered applicable to other countries with 
similar healthcare standard, and to patients with equivalent comorbid burden and comparable 
surgical risk profile. Study II and III were single-centre studies, the study cohorts were well-
defined but smaller, limiting the possibility to generalize these results to other surgical 
population. These studies are conceptually more hypothesis generating by design. However, 
the use of an individual, relative to baseline, definition of IOH has advantages; patients with 
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preoperative normal BP could be included, thus increasing the generalizability of the study 
results to low-BP patients. Moreover, patients with preoperative elevated creatinine were 
included in the study III cohort, the influence of hypotension on patients with pre-existing 
renal insufficiency could therefore be explored and conclusions drawn regarding this patient 
group. In study IV, the main results could safely be generalized to a surgical population with 
the same risk profile. This study was multi-centre and the sample was drawn from a large 
well-defined cohort. However, the majority of cases were patients with an elevated risk factor 
burden, and the ability to estimate the IOH associated MI risk among patients with a low 
underlying risk was limited. Sensitivity analysis illustrated a lower relative impact of IOH in 
low risk patients and a higher impact among high risk patients, suggesting that we may 
underestimate the absolute excess in patients with a high-risk profile. Correspondingly, in 
low risk patients, the effect of intraoperative hypotensive events may be overestimated.  
Internal validity 
Internal validity is related to systematic errors, in methodology or study design.78 Systematic 
errors, or bias,77,79 are the consistent deviations of measurements away from the true path, 
unrelated to sample size.  
Misclassification bias 
In epidemiological research, there is an inherent risk of misclassification, or information, 
bias.79 Quality of data, often dependent on registry accuracy and coverage, variable definition 
and categorization, are potential areas. Random misclassifications, unrelated to exposure or 
outcome, generally result in dilution of effects, i.e. bias towards the null. Differential 
misclassifications, of exposure or outcome, may have an important impact on the results, 
either by creating false – or concealing existing – associations. In study I, data were obtained 
from large registries and databases, with possible reporting bias and errors in coding and 
subsequent risk of misclassification of both outcome, MI diagnosis, and risk factors, i.e. 
comorbidities. Although the NPR have close to complete coverage of in-patient data, 
information from primary care is lacking. To maximise the coverage of comorbid history, 
data linkage to the Swedish Prescribed Drug Register,62 for information of dispensed drug 
prescriptions within five years before surgery, was performed. In the Swedish Cause of Death 
Registry, over 99% of all deaths are reported,59 so mortality rates reported in study I are 
reliable. In study IV, dates of death were validated in electronic medical records. Study I was 
not a prospective study, it cannot be ensured that all physicians across Sweden who 
diagnosed cases of MI included in this study used the universal definition,31 which may 
influence the estimated MI-incidence. In study II, III and IV, parts of the data collection were 
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performed manually, preoperative BP and laboratory values were obtained from electronic 
medical records and intraoperative data from paper charts, with risk of errors. The accuracy 
of the recordings of the main exposure, IOH, was followed, to test how well hypotensive 
events during surgery and anesthesia were transferred to paper records. The validation trial 
showed that 13 out of 30 patients had major hypotensive events captured by the electronic 
monitors, 9 patients had hypotensive events recorded in the anaesthetic paper records. Thus, 
there were no overestimated hypotensive events, rather a trend that the anaesthetic staff was 
underestimating the lower limit of intraoperative BP recordings. 
Selection bias 
Selection bias is a systematic error79,80 related to the selection process of study participants. 
All four studies are registry-based, with pre-defined inclusion- and exclusion criteria, and 
participation was not voluntary, reducing risk of selection bias. However, in study I, the lack 
of cardiac biomarker information in all patients introduce a potential bias; with cardiac 
troponins, the possibility of identifying all cases of myocardial injury and infarction would be 
increased, since many of these incidents are clinically silent.81 These limitations also apply to 
study IV, since cases and controls were obtained from the same source population. Troponins 
may be analysed more readily in elderly/high-risk patients, possibly leading to an over-
representation of more severe and frail patients among cases. In addition, an observed episode 
of IOH may increase the likelihood of a MI being diagnosed, leading to over-estimation of 
the risk. In study II and III, the pre-set strict inclusion criteria of all adult patients undergoing 
major elective non-cardiac surgery, within a specific time frame, and who, in advance, were 
planned for an overnight admission at the postoperative unit, reduce risk of selection bias. 
Confounding 
Confounding factors are, by definition, covariates related to exposure and outcome without 
partaking in the causal pathway. Confounding is inevitable in all research.79 Strategies to 
handle, and minimize, the impact and distortion of study results includes using the correct 
study design approach, by randomization, restriction and matching when possible, and, in the 
analysis phase, by stratification and regression. 
In Study I, confounding was handled statistically using regression analyses, stratification and 
restriction. The large study cohort freely enabled variable categorization and adjustment for 
all potential confounders, without risk of losing power. The selection of covariates was based 
on clinical consideration and on whether the addition to the multivariable models changed the 
relative risk estimates. Confounding by indication refers to when a determinant of the 
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outcome that is present in patients at high risk, with estimated poor prognosis, leads to 
differences in care between the exposed and non-exposed, and between cases and non-
cases.82 The outcome may, in fact, be caused by the indication for which the exposure was 
used. Confounding by severity is a variant, when disease severity acts as confounders. There 
is a risk of confounding by indication in study I, troponins may be more frequently analysed 
in elderly/high-risk patients in the perioperative period, possibly identifying and diagnosing 
more clinically silent MIs in this patient group.  
Study II and III were smaller and dependent on the rule of ten in the modelling process.83 
Even if this rule of thumb, that logistic and proportional hazard models should be used with a 
minimum of 10 outcome events per predictor variable, has been questioned.84 Thumb rules 
are valuable tools and useful signals for potential trouble but there are statistical situations 
when this rule may be too rigid, as in sensitivity analyses undertaken to explore the influence 
of confounding in observational studies. In study II and III, the selection of potentially 
confounding factors was based on clinical experience in conjunction with p-values in the 
bivariate analysis. However, there is risk of residual confounding. 
In study IV, control subjects were matched to cases by age, comorbidities and surgical risk 
factors, reducing risk of confounding and increasing the possibility to evaluate the effect of 
the main exposure on the primary outcome. 
Effect modification and interaction 
Effect modification has to be considered when the association between an exposure and 
outcome variable is affected by another variable. Unlike a confounder, the effect modifier 
takes part in the causal pathway and may affect the magnitude the exposure effect on the 
outcome of interest. Interaction (synergistic) is when the joint effect of two covariates is 
higher than the individual effects on a specific outcome.78,85 Stratification and interaction 
tests are valuable statistical tools to handle potential effect modifying – and interacting - 
influence. 
In study I, the large amount of data and different risk assessments entail existence of 
interaction, and multicollinearity, which was taken into account in the statistical analyses and 
the result interpretation. Pre- and intraoperative risk factors were carefully evaluated in all 
studies using interaction tests and stratified analyses. Furthermore, with regards to BP levels 
during surgery, intraoperative blood loss is a risk factor closely associated with hemodynamic 
instability and has to be considered both as an effect modifying risk factor and a confounder, 
discussed in more detail under clinical interpretations. In study IV, effect modification by 
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preoperative BP, risk group, day of MI diagnosis and tachycardia were thoroughly assessed 
using internally stratified analyses (table 20). 
Reverse causation 
In study IV, reverse causality must be considered as a potential bias. From data, we were 
statistically unable to exclude the possibility that the hypotensive event was a consequence of 
a major MI occurring on the operating table. However, from a clinical perspective, MI 
following a fall in BP is a more probable course. Moreover, all cases with a major 
hypotensive episode during surgery, leading to cardiac biomarker-analysis after surgery 
despite absence of other clinical signs and subjective ischemic symptoms, were excluded. 
This was done to minimize the risk of reverse causation. 
Immortal time bias 
In study IV, controls were selected using cumulative incidence sampling, all controls were 
bound to be alive at 30 days. Differences in 30-day mortality could not be analysed, due to 
immortal time bias in controls; this sampling scheme precludes estimation of 30-day 
mortality related to MI. 
Precision  
The accuracy and replicability of research results depends on internal validity, as described 
above, and precision. All research, as life in general, is inevitably affected by chance. Risk of 
random errors are related to study sample size. A measure of the unpredicted variability in a 
study finding is p-values and CI. The p-value stands for the probability that the difference 
between groups in a population is caused by chance, if the null hypothesis comprises that the 
groups are equal. The meaning of CI intervals is to illustrate what 95% of the point estimates 
would be if a new study population was sampled from the same source population, i.e. the 
likelihood that the true value lies within this interval. 
In study I, the risk of random errors should be minimal due to the large sample size. The 
accurate sampling procedure of cases and controls from the study I cohort, reduce risk of 
random errors in study IV. Study II and III are conducted with smaller study samples, hence 





INTERPRETATIONS OF FINDINGS 
Perioperative MI – incidence and risk factors 
Myocardial infarction, fulfilling the universal definition, occurring in the perioperative period 
is an overall rare condition. Our study results indicate that the risk elevation is associated with 
increasing age, surgical procedure, and preoperative cardiovascular comorbidity. A small 
subset of high-risk patients is especially affected by perioperative cardiac morbidity.72 In the 
study I cohort, the perioperative MI incidence was half of the incidence (0.9%) reported in a 
large study of MI in non-cardiac surgical patients.86  The age inclusion cut-off was higher 
(≥45y) but median age in the cohorts similar, as were patient factors and surgical procedures 
carrying highest risk. Restriction of our cohort to patients ≥45y resulted in an incidence of 
0.5%. There was a major difference how MI patients were identified, MI diagnosis reported 
during the surgical inpatient hospitalization were defined as cases without a specified pre- or 
postoperative time span, with consequential risk of reversed causality and confounding by 
indication, potentially leading to higher incidence. Using the unique Swedish Quality 
Registry (Swedeheart) and the National Patient Register, all MIs within a pre-specified period 
(30 days) after surgery, including patients with MI type 2, not referred to cardiology clinics or 
subject for cardiac intervention, could be identified. However, since these incidents often are 
clinically silent,81 the lack of cardiac biomarkers in all patients is vital; with cardiac 
troponins, the possibility of identifying all cases of myocardial injury and infarction would be 
increased. 
Reports on long-term mortality after perioperative MI are lacking. In a smaller study of 
patients with perioperative myocardial injury in non-cardiac surgery, 8.9% died <30 days and 
22.5% <1 year after surgery. Adjusted HR for 30-day and 1-year mortality was 2.73 and 
1.58.23 This cohort constituted of high-risk patients, defined by age and comorbidities, 
explaining the higher overall mortality (30-day- and 1-year mortality was 2.8% vs 11.2%), 
and the subsequent lower relative risks, compared to ours. A large multinational study 
reported overall an mortality of 1.2-1.8% in major non-cardiac surgical patients (equal to our 
cohort mortality) and tripled 30-day mortality in patients with perioperative myocardial injury 
(adjusted HR, 3.69).30,87 In a recent study evaluating MI incidence in a US surgical cohort, in-
hospital mortality was 18% in patients with in-hospital MI, and corresponding adjusted OR 
5.76.86 
In study I, a high death-rate was identified among patients developing MI <30 days; 26% at 
30-days, 35% at 90-days and 45% one year after surgery. Elevated absolute risks were related 
to extensive preoperative comorbid burden and high age. After adjustment for demographic 
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variables and comorbidities, patients with perioperative MI had five-fold increased risk of 
dying within 30 days after surgery, in-line with the in-hospital mortality following 
perioperative MI previously reported86 and higher compared to the doubled - and tripled - 30-
day mortality after myocardial injury described above.23,87 A plausible explanation would be 
that only patients with a verified MI diagnosis fulfilling the universal criteria16 are cases in 
our study, some myocardial injuries are diagnosed as MI type 2, and included, but 
asymptomatic myocardial injuries are not. One could credibly argue that this would result in 
a worse outcome, although there are studies implying that MI, symptomatic or asymptomatic, 
carries equally poor prognosis.20 Long-term mortality was increased, as expected. Mortality 
rates beyond 30 days were doubled in patients with MI up to 90 days after surgery, then the 
risk-increase declined. Between day 91-365, there was a remaining 37% increased mortality. 
Hence, the major risk elevation of death following perioperative MI occur within the first 3 
postoperative months, possibly because of depletion of susceptible individuals. Since elderly, 
diseased patients who develop perioperative MI are more likely to die early, patients 
surviving the first 90 days are a more resistant population. Residual confounding, interaction 
factors remaining after adjustment, could be another explanation. As the fact that MI is a 
heterogenic diagnosis, with a spectrum from fatal types to more benign myocardial injuries.  
Intraoperative hypotension and perioperative MI risk 
As mentioned, hemodynamic instability is common in a perioperative setting and associated 
with perioperative cardiac injury, and increased mortality in high-risk surgical 
patients.9,11,22,47,48 Results presented in study IV are in line with previous studies,9,11,48,88-91 but 
with a more pronounced effect of the intraoperative hypotensive events. The nested case-
control design, and the use of a well-characterized cohort of high-risk surgical patients as 
source population, gives reliable estimates of associations even in rare outcomes, reducing 
risk of residual confounding. Further possible reasons for the strong association are the 
outcome – and exposure – definitions. Only symptomatic MIs, fulfilling the universal 
definition, are included, myocardial injuries are not. Regarding exposure; both pre- and 
intraoperative BP values were accessible which enabled the comparison between different 
hypotension definitions: relative to baseline (mmHg), relative to baseline (%) and absolute 
intraoperative thresholds. All resulted in similar risk estimates with a gradual elevation of MI-
risk in relation to an increasing fall in BP. Statistically, a relative drop in mmHg from 
individual baseline was favoured. From a clinical perspective, the reduction in mmHg from 
individual baseline is an appealing definition, a lowest acceptable threshold could be easily 
determined in the OR, before the anaesthetic induction. 
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There is scarce evidence of optimal blood pressure (BP) thresholds to maintain adequate 
perfusion and oxygenation in critical organs during anaesthesia and surgery. Various 
definitions of perioperative hypotensive events exist in the literature.51 Previous 
investigations are limited by the use of specific systolic- or mean BP and may underestimate 
IOH as a risk factor. Individualized hypotension definitions are theoretically better when 
investigating the risk of perioperative organ injury. In patients with a pre-existing 
hypertension diagnosis the auto-regulatory capacity in the kidney and brain, an essential 
mechanism to preserve optimal blood perfusion when systemic BP fluctuates, is likely 
affected.92,93 Thus higher BP may be beneficial for certain high-risk patients.9,47,88,90 The 
advantage of using individual IOH definitions was also strengthened by a randomized 
controlled trial evaluating BP targets in patients with septic shock, where outcomes were 
improved by high BP targets only in patients with known hypertension.94 However, there are 
studies showing that absolute and relative thresholds are comparable in their ability to 
discriminate patients with myocardial and kidney injury from those without.88 A randomized 
study showed that targeting an individualized SBP, as compared with standard management, 
reduced risk of postoperative organ dysfunction.91 Patients in the individualized treatment 
group had significantly lower rates of renal dysfunction and a lower risk for altered 
consciousness and confusion than patients in the standard treatment group. 
The underlying mechanisms of hypotension occurring closely after the induction and 
episodes later during surgery are most certainly completely different. The former being 
related to the cardio-depressant effect of the anaesthetic agents (and possibly an un-attentive 
anaesthetist) and the latter rather associated with other intra-surgical events, such as excessive 
bleeding, etc. In study IV, various intraoperative events, such as tachycardia, hypoxia, blood 
loss, low Hb-values and fluid overload were associated with MI. However, no significant 
effect on the strong association between hypotension and MI was seen. Increased heart rate is 
a physiological consequence of low BP, and a response to pain and insufficient anaesthesia, 
but doesn’t act as a cause of hypotension. Tachycardia was therefore considered as a 
contributor in the causal pathway between hypotension and MI, rather than a confounder. 
Intraoperative heart rate >100 bpm has previously been identified as a risk factor of 
perioperative myocardial injury and infarction (OR 1.27 and 1.34) and an indication of a 
slightly stronger association in combination with an intraoperative SBP <100 mmHg has 
been shown95, in line with the results in study IV. The stratified analyses also highlighted a 
more pronounced effect of hypotension in higher risk patients and on MI-development 
closely after surgery. 
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Importantly, even though the relative risk of clinically manifested MI associated with a large 
fall in BP was 20-fold, this corresponds to a low absolute excess risk for the vast majority of 
operated patients. However, for patients with a very high preoperative risk factor burden the 
associated absolute excess risk was considerable. 
Intraoperative hypotension - perioperative myocardial and kidney injury 
Elevated levels of the cardiac biomarkers hs-cTnT, as an indication of myocardial injury, 
following non-cardiac surgery is now a well-known warning flag. In a large, recent study, one 
in 10 patients with myocardial injury after non-cardiac surgery were deceased within 30 days 
and more than 80% of these patients would not have been identified without the postoperative 
troponin measurement.96 Associations between peak postoperative fourth generation TnT and 
30-day mortality have been reported previously.30 In a small study of 140 patients, cardiac 
troponin I was associated to major adverse cardiac events but no differences during the 
perioperative course was found.97 Two meta-analyses in recent years have detailed the 
relationship between postoperative leakage of troponin and mortality. One included nine 
studies to investigate how elevation of troponin below the diagnostic threshold for 
perioperative MI, without symptoms or ischemic electrocardiography changes or 
echocardiography signs, was predictive of all-cause mortality at 30 days after vascular 
surgery.98 In the other, fourteen studies were analysed, enrolling 3,318 patients with 459 
deaths, demonstrating increased troponin postoperatively to be an independent predictor of 
all-cause mortality one year after non-cardiac surgery.99 
Interestingly, the association between intraoperative hypotension and myocardial injury, in 
study II, was consistent independently of baseline comorbidity.48 Chronic antihypertensive 
medications were not independently associated with myocardial injury or intraoperative 
hypotensive events. Since ACE inhibitors are known to increase intraoperative BP instability, 
national guidelines recommend patients to discontinue this treatment on day of surgery. 
Furthermore, preoperative comorbidity risk factors were more prevalent in cases with high 
hs-cTnT (>14 ng/l) after surgery as well as in patients with perioperative MI. Notably, almost 
one in four of the patients with perioperative MI had a negative hs-cTnT in the early 
postoperative phase, possibly indicating later adverse events during hospitalization. In line 
with previous findings,20 most MI’s occurred within 48 hours of surgery. 
Despite uncertainties regarding BP thresholds, we do know that over 10 of the 200 million 
adults undergoing major non-cardiac surgery annually will suffer elevation of troponin within 
30 days.30,100 In a randomized control trial of over 8000 patients, 1.4% suffered vascular 
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death, 0.5% suffered stroke, 0.5% nonfatal cardiac arrest and 5.7% suffered myocardial injury 
in the first 30 postoperative days.101 Most researchers have focused on association between 
postoperatively elevated biomarkers and adverse outcomes, suggesting a systematic use of 
biomarkers, such as cardiac troponins, to find patients at risk. 
The findings in study III confirm published data on the association between hypotension and 
AKI.9,11,47,102-104 In a review of 20 studies receiving perioperative hemodynamic optimization 
indeed were at decreased risk of renal impairment.105 In a study investigating outcomes of 
5,127 patients showed that time spent under different levels of lowered MAP were associated 
with AKI.47 However, in that study, patients with baseline MAP <65 were excluded, making 
it impossible to study the effect of IOH in patients with preoperative normal BP. As 
mentioned above, a comparable ability to discriminate patients with myocardial or kidney 
injury using both absolute and relative MAP thresholds was identified. MAP <65 mmHg, or a 
relative decrease of 20% below baseline, were related to myocardial and kidney injury, with 
an increased risk at lower absolute thresholds, and prolonged hypotension. Notably, when a 
IOH definition close to ours was used, MAP below 50% of preoperative values, lasting for 5 
minutes, significantly increased the risk for myocardial and kidney injury.88 In contrast to that 
study, with a 5.6% AKI incidence, our cohort had five times that. This is likely explained by 
our cohort being subjected to high risk surgery, where all patients were scheduled for an 
overnight admission to the postoperative unit. As previously highlighted, a large systematic 
review, including 91 observational studies, reported an AKI incidence rate of 22.3% (95% CI 
19.8 to 25.1).36 
Since patients with preoperative elevated creatinine were included in the study III cohort, in 
contrast to others studies,9 the influence of hypotension on patients with pre-existing renal 
insufficiency could be explored. Interestingly, the findings in study III showed that patients 
with an elevated preoperative creatinine had an elevated risk of perioperative AKI with or 
without hypotension, whilst the risk among those without a preoperative lowered glomerular 
filtration rate were more negatively affected of an intraoperative hypotensive event. 
As addressed in methodological considerations, intraoperative blood loss must be considered 
both as a potential effect modifying risk factor and a confounder, when the association 
between intraoperative hypotension and organ injury is evaluated. A sudden substantial 
bleeding during surgery is most often associated with a period of lower BP readings, before 
that is corrected with crystalloid fluids, blood transfusion, inotropes, or vasopressors. It may 
therefore be difficult to distinguish if the increased risk of organ ischemia is because of the 
fall in BP or if it could be related to the loss of haemoglobin and the reduced capacity of 
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oxygen transport.10 In study III, there was a strong association between the estimated 
intraoperative blood loss and AKI in the bivariate analyses but, since we are unable to 
determine the temporal relationship between the two, our findings cannot contribute to the 
reasoning above. The addition of this variable to the multivariable model resulted only in a 
slight attenuation in the relative risk, suggesting there was no significant effect on the 
association between IOH and perioperative AKI. 
The relation between fluid balance and AKI is complex, since fluid overload can be the 
cause, as in renal compartment syndrome or renal venous congestion,106 or rather a 
consequence of a symptomatic AKI when administered (incorrectly) as a treatment of anuria. 
As for blood loss, we have insufficient data on the timing of fluid administration, to which 
extent it is given intra- or postoperatively, and can therefore not discuss the relation to the 


















As we are entering an era of individualized medicine,107,108 where the aim is to optimize 
clinical decisions about a patient’s care by utilizing all available data, the application of 
baseline individual information on physiological parameters is paramount. Results yielded in 
this thesis, and in multiple previous studies, show that hypotension intraoperatively matters 
and that dangerously low levels of hypotension, especially when it comes to patients-at-risk, 
exist. An elderly person with known hypertension is likely to have higher risk for adverse 
events at differing thresholds than patients with normal baseline BP. The next important step 
is to determine if individualized, goal directed anaesthesia can minimise these risks.  
This is the first project that describe the incidence and characteristics of perioperative MI 
among patients undergoing non-cardiac surgery in Sweden. Furthermore, the definition of a 
hypotensive event as a relative decrease from each patients’ individual baseline, rather than 
an absolute threshold, is unique. As mentioned, previous studies may be limited by the use of 
specific systolic- or mean blood pressure, which may have underestimated intraoperative 
hypotension as a risk factor. 
MI, myocardial and kidney injury after non-cardiac surgery are clinical realities and have a 
significant impact on postoperative morbidity and mortality. In patients developing a 
perioperative – clinically significant – MI, 30-day mortality is increased 5-fold and the risk 
increase remains; non-fatal perioperative MI-patients have a doubled risk of death within 3 
month, and a persistent 37% excess mortality at one year after surgery. Patients developing 
MI after surgery are at increased risk of other types of complications, such as respiratory 
failure, pneumonia, wound infection, deep venous thrombosis and confusion. They also have 
a prolonged postoperative length of stay and more commonly need treatment at the intensive 
care unit.21,22,30,81,109 The studies included in this thesis identified IOH as a possible 
contributor to MI, irrespective of MI type, and associated with myocardial and kidney injury. 
IOH was equally common among patients with fatal and non-fatal MI, suggesting that IOH is 
merely a trigger and that the mortality is a result of other risk factors. Overall, four out of five 
MI’s were attributable to a serious IOH in the study population. Perioperative MI is an 
overall rare condition explaining why these findings have not been identified previously. 
Notably, IOH was significantly more frequent in lower risk- than in higher risk-groups, 
implying more vigilant anaesthesia in comorbid and fragile patients. Importantly, 
perioperative hemodynamic instability can be prevented in most clinical situations. Adequate 
intravascular volume and organ perfusion pressure can be maintained through attentive 
medical treatment using vasoactive drugs, and protocolized hemodynamic algorithms to 
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guide delivery of intravenous fluids and maximize stroke volume. An increasing number of 
elderly patients, with cardiovascular risk factors, are undergoing extensive surgery. Avoiding 
IOH, by an attentive anaesthetic caretaking, during and after surgery, could lower the risk of 
perioperative MI, as well as other postoperative complications, improving quality of life for 
these patients and reducing costs for the society. These findings are important, as 
individualized perioperative medicine moves from bench to bedside and anaesthetic 
management to minimise hypotension is doable. Large scale clinical trials are needed to 























• Comorbid patients, undergoing high-risk non-cardiac surgery, are at increased risk of 
perioperative cardiac morbidity. This high-risk population should be targeted to 
improve perioperative outcomes.  
• Intraoperative hypotension may be an important event contributing to cardiac and 
kidney injury in the perioperative period. Patients with myocardial injury are possibly 
at increased risk of developing myocardial infarction. 
• Intraoperative hypotension may be a important contributor to clinically significant 
perioperative MI. The high absolute MI-risk associated with IOH, among a growing 
population of patients with a high risk-burden undergoing surgery, suggests that 
increased vigilance of BP control in these patients may be beneficial. 
• Prospective studies are desirable, where patients are randomised to having an 
anesthesiologic procedure with avoidance of intraoperative hypotension. This will 
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